J Gen Virol Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 75 (1994), 2271-2276; DOI 10.1099/0022-1317-75-9-2271
© 1994 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Christensen, N. D.
Right arrow Articles by Kreider, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Christensen, N. D.
Right arrow Articles by Kreider, J. W.
Agricola
Right arrow Articles by Christensen, N. D.
Right arrow Articles by Kreider, J. W.

Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titres of neutralizing antibodies

Neil D. Christensen1, Reinhard Höpfl3, Susan L. DiAngelo1, Nancy M. Cladel1, Susan D. Patrick1, Patricia A. Welsh1, Lynn R. Budgeon1, Cynthia A. Reed1 and John W. Kreider1,2,

1 Department of Pathology,
2 Department of Microbiology and Immunology, The Milton S. Hershey Medical Center, Hershey, Pennsylvania 17033, U.S.A.
and3 Department of Dermatology, University of Innsbruck, Innsbruck, Austria

Baculovirus-expressed human papillomavirus type 11 (HPV-11) major capsid protein (L1) virus-like particles (VLPs) were produced in insect cells and purified on CsCl density gradients. The VLPs retained conformational neutralizing epitopes that were detected by a series of HPV-11-neutralizing monoclonal antibodies. Electron microscopy determined that the HPV-11 L1 VLPs were variable in size with a surface topography similar to that of infectious HPV-11. The VLPs were very antigenic, and induced high titres of neutralizing antibodies in rabbits and mice when used as an immunogen without commercial preparations of adjuvant. These VLP reagents may be effective vaccines for protection against HPV infections.

Received 18 January 1994; accepted 25 March 1994.


This article has been cited by other articles:


Home page
J. Virol.Home page
T. Senger, M. R. Becker, L. Schadlich, T. Waterboer, and L. Gissmann
Identification of B-Cell Epitopes on Virus-Like Particles of Cutaneous Alpha-Human Papillomaviruses
J. Virol., December 15, 2009; 83(24): 12692 - 12701.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Schellenbacher, R. Roden, and R. Kirnbauer
Chimeric L1-L2 Virus-Like Particles as Potential Broad-Spectrum Human Papillomavirus Vaccines
J. Virol., October 1, 2009; 83(19): 10085 - 10095.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
N. Thones, A. Herreiner, L. Schadlich, K. Piuko, and M. Muller
A Direct Comparison of Human Papillomavirus Type 16 L1 Particles Reveals a Lower Immunogenicity of Capsomeres than Viruslike Particles with Respect to the Induced Antibody Response
J. Virol., June 1, 2008; 82(11): 5472 - 5485.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
R. Z. Rizk, N. D. Christensen, K. M. Michael, M. Muller, P. Sehr, T. Waterboer, and M. Pawlita
Reactivity pattern of 92 monoclonal antibodies with 15 human papillomavirus types
J. Gen. Virol., January 1, 2008; 89(1): 117 - 129.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
K. Heim, G. Hudelist, A. Geier, H. Szedenik, N. D. Christensen, N. Concin, A. Bergant, B. Volgger, K. Czerwenka, and R. Hopfl
Type-Specific Antiviral Antibodies to Genital Human Papillomavirus Types in Mothers and Newborns
Reproductive Sciences, December 1, 2007; 14(8): 806 - 814.
[Abstract] [PDF]


Home page
J. Virol.Home page
P. M. Day, C. D. Thompson, C. B. Buck, Y.-Y. S. Pang, D. R. Lowy, and J. T. Schiller
Neutralization of Human Papillomavirus with Monoclonal Antibodies Reveals Different Mechanisms of Inhibition
J. Virol., August 15, 2007; 81(16): 8784 - 8792.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
Y. Xu, Q. Wang, Y. Han, G. Song, and X. Xu
Type-specific and cross-reactive antibodies induced by human papillomavirus 31 L1/L2 virus-like particles
J. Med. Microbiol., July 1, 2007; 56(7): 907 - 913.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
J. Ryding, L. Dahlberg, M. Wallen-Ohman, and J. Dillner
Deletion of a major neutralizing epitope of human papillomavirus type 16 virus-like particles
J. Gen. Virol., March 1, 2007; 88(3): 792 - 802.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
Y. Y. Studentsov, G. Y. F. Ho, M. A. Marks, R. Bierman, and R. D. Burk
Polymer-Based Enzyme-Linked Immunosorbent Assay Using Human Papillomavirus Type 16 (HPV16) Virus-Like Particles Detects HPV16 Clade-Specific Serologic Responses
J. Clin. Microbiol., July 1, 2003; 41(7): 2827 - 2834.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. L. Finnen, K. D. Erickson, X. S. Chen, and R. L. Garcea
Interactions between Papillomavirus L1 and L2 Capsid Proteins
J. Virol., April 15, 2003; 77(8): 4818 - 4826.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. E. Embers, L. R. Budgeon, M. Pickel, and N. D. Christensen
Protective Immunity to Rabbit Oral and Cutaneous Papillomaviruses by Immunization with Short Peptides of L2, the Minor Capsid Protein
J. Virol., August 28, 2002; 76(19): 9798 - 9805.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A.-L. Combita, A. Touze, L. Bousarghin, N. D. Christensen, and P. Coursaget
Identification of Two Cross-Neutralizing Linear Epitopes within the L1 Major Capsid Protein of Human Papillomaviruses
J. Virol., June 5, 2002; 76(13): 6480 - 6486.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
Y. Y. Studentsov, M. Schiffman, H. D. Strickler, G. Y. F. Ho, Y.-Y. S. Pang, J. Schiller, R. Herrero, and R. D. Burk
Enhanced Enzyme-Linked Immunosorbent Assay for Detection of Antibodies to Virus-Like Particles of Human Papillomavirus
J. Clin. Microbiol., May 1, 2002; 40(5): 1755 - 1760.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Fligge, F. Schafer, H.-C. Selinka, C. Sapp, and M. Sapp
DNA-Induced Structural Changes in the Papillomavirus Capsid
J. Virol., August 15, 2001; 75(16): 7727 - 7731.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Gerber, C. Lane, D. M. Brown, E. Lord, M. DiLorenzo, J. D. Clements, E. Rybicki, A.-L. Williamson, and R. C. Rose
Human Papillomavirus Virus-Like Particles Are Efficient Oral Immunogens when Coadministered with Escherichia coli Heat-Labile Enterotoxin Mutant R192G or CpG DNA
J. Virol., May 15, 2001; 75(10): 4752 - 4760.
[Abstract] [Full Text]


Home page
Int ImmunolHome page
D. M. Da Silva, M. P. Velders, J. D. Nieland, J. T. Schiller, B. J. Nickoloff, and W. M. Kast
Physical interaction of human papillomavirus virus-like particles with immune cells
Int. Immunol., May 1, 2001; 13(5): 633 - 641.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
A. Petter, K. Heim, M. Guger, A. Ciresa-Kö nig, N. Christensen, M. Sarcletti, U. Wieland, H. Pfister, R. Zangerle, and R. Höpfl
Specific serum IgG, IgM and IgA antibodies to human papillomavirus types 6, 11, 16, 18 and 31 virus-like particles in human immunodeficiency virus-seropositive women
J. Gen. Virol., March 1, 2000; 81(3): 701 - 708.
[Abstract] [Full Text]


Home page
J. Gen. Virol.Home page
G. Sibbet, C. Romero-Graillet, G. Meneguzzi, and M. S. Campo
{alpha}6 integrin is not the obligatory cell receptor for bovine papillomavirus type 4
J. Gen. Virol., February 1, 2000; 81(2): 327 - 334.
[Abstract] [Full Text]


Home page
J. Virol.Home page
R. C. Rose, W. I. White, M. Li, J. A. Suzich, C. Lane, and R. L. Garcea
Human Papillomavirus Type 11 Recombinant L1 Capsomeres Induce Virus-Neutralizing Antibodies
J. Virol., July 1, 1998; 72(7): 6151 - 6154.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. P. McCarthy, W. I. White, F. Palmer-Hill, S. Koenig, and J. A. Suzich
Quantitative Disassembly and Reassembly of Human Papillomavirus Type 11 Viruslike Particles In Vitro
J. Virol., January 1, 1998; 72(1): 32 - 41.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1994 by the Society for General Microbiology.